(Q85193723)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20946166%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20946166%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20946166

2 August 2024

direct Xa inhibitor

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20946166

2 August 2024

author name string

A. Hillarp

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20946166

2 August 2024

F. Baghaei

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20946166

2 August 2024

I. Fagerberg Blixter

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20946166

2 August 2024

K. M. Gustafsson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20946166

2 August 2024

L. Stigendal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20946166

2 August 2024

M. Sten-Linder

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20946166

2 August 2024

K. Strandberg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20946166

2 August 2024

T. L. Lindahl

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20946166

2 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20946166

2 August 2024

publication date

1 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20946166%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

15 February 2020

http://www.jthjournal.org/article/S1538783622083179/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20946166

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1538-7836.2010.04098.x

2 August 2024

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04098.X

https://api.elsevier.com/content/article/PII:S1538783622083179?httpAccept=text/xml

2 August 2024

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04098.X

https://api.elsevier.com/content/article/PII:S1538783622083179?httpAccept=text/plain

2 August 2024

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04098.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1538-7836.2010.04098.x/fullpdf

2 August 2024

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04098.X

Journal of Thrombosis and Haemostasis

2 August 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20946166%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20946166%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20946166%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

133-139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20946166%20AND%20SRC:MED&resulttype=core&format=json

Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939--an oral, direct Factor Xa inhibitor--after multiple dosing in healthy male subjects

15 February 2020

cites work

2

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04098.X

Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor

2 August 2024

3

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04098.X

In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939--an oral, direct Factor Xa inhibitor

2 August 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04098.X

Population model of the pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor xa inhibitor--in healthy subjects

2 August 2024

5

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04098.X

Effects of the oral, direct factor xa inhibitor rivaroxaban on platelet-induced thrombin generation and prothrombinase activity

2 August 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04098.X

Monitoring direct FXa-inhibitors and fondaparinux by Prothrombinase-induced Clotting Time (PiCT): relation to FXa-activity and influence of assay modifications

2 August 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04098.X

Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjects

2 August 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04098.X

Population pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in patients undergoing major orthopaedic surgery.

2 August 2024

9

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04098.X

Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor xa inhibitors in development

2 August 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04098.X

Safety, pharmacokinetics and pharmacodynamics of single/multiple doses of the oral, direct Factor Xa inhibitor rivaroxaban in healthy Chinese subjects

2 August 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04098.X

INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples.

2 August 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04098.X

In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban

2 August 2024

14

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04098.X

A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study

2 August 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04098.X

Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor

2 August 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2010.04098.X

2 August 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20946166%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference